Test results in hand, Thrive raises $257M to push liquid biopsy toward approval

News from @thrivedetect : Series B, new investors, and progress towards a breakthrough cancer detection blood test.

Read More

Bill Maris, recruits ex-Googlers to Section 32

COVID-19 has only made it clearer that the tools for living a healthy and good life are not fairly or humanely distributed. Recent global events have shined a light on how important Section 32’s mission is.” said Bill Maris, founder of Section 32.

Read More

Bill Maris, who started Google’s VC arm, brings on new hires.

Bill Maris talked to CNBC today about what Section 32 is investing in, looking at, thinking about –>

Read More

Our place in the future of technology and healthcare

When I started Section 32 three years ago, I wanted to create a venture fund that could focus on areas where technology can make a real difference on the most important aspects of our lives.

My last job before Section 32 was as founder and CEO at Google Ventures, and even though I loved my time there, I saw a need for a different type of fund […]

Read More

An early believer in Moderna Therapeutics on the core investing lesson behind a big coronavirus bet

CNBC interviewed our own @MichaelPellini about long-term biotech bets, avoiding reactionary investments and the undervalued diagnostics industry.

Read More

Diagnostics firm says new Covid-19 test could be used 1 million times a week

“Remember that we need to go to tens of millions per week, or even per day, but every step does count.” – @MichaelPellini

Read More